Bayesian competing risks analysis without data stratification
نویسندگان
چکیده
منابع مشابه
Bayesian Analysis of Progressively Censored Competing Risks Data
In this paper we consider the Bayesian inference of the unknown parameters of the progressively censored competing risks data, when the lifetime distributions are Weibull. It is assumed that the latent cause of failures have independent Weibull distributions with the common shape parameter, but different scale parameters. In this article, it is assumed that the shape parameter has a log-concave...
متن کاملBayesian Analysis of Bivariate Competing Risks Models
Absolutely continuous bivariate exponential (ACBVE) models have been widely used in the analysis of competing risks data involving two risk components. For such an analysis, frequentist approach often runs into difficulty due to a likelihood containing some nonidentifiable parameters. With an end to overcome this nonindentifiability, we consider Bayesian procedures. Utilization of informative p...
متن کاملSemi-Competing Risks Data Analysis
Hospital readmission is a key marker of quality of healthcare; it has been used to investigate variation in quality among patients in a broad range of clinical contexts and has become an important policy measure. Notwithstanding its widespread use, however, readmission remains controversial as a measure of quality. Among the concerns raised, whether and how patient deaths are handled in the ana...
متن کاملSimulating competing risks data in survival analysis.
Competing risks analysis considers time-to-first-event ('survival time') and the event type ('cause'), possibly subject to right-censoring. The cause-, i.e. event-specific hazards, completely determine the competing risk process, but simulation studies often fall back on the much criticized latent failure time model. Cause-specific hazard-driven simulation appears to be the exception; if done, ...
متن کاملCumulative incidence in competing risks data and competing risks regression analysis.
Competing risks occur commonly in medical research. For example, both treatment-related mortality and disease recurrence are important outcomes of interest and well-known competing risks in cancer research. In the analysis of competing risks data, methods of standard survival analysis such as the Kaplan-Meier method for estimation of cumulative incidence, the log-rank test for comparison of cum...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Epidemiology and Global Health
سال: 2020
ISSN: 2213-3984
DOI: 10.1016/j.cegh.2019.08.010